Nia Health Raises $4.0M Seed

Nexio

The world of payments is a confusing and messy thing, but it doesn’t have to be. You just want to sell your product and services, or enable others to do just that. Where do you start? Where do you even begin? That is Nexio’s mission and passion. We strive to help companies of all sizes disentangle the complexity of payments, and plan for tomorrow. Simplifying complexity produces results. Since 2007, Nexio’s goal is turning payments complexities into growth and simplicity.

Arcturus Therapeutics

Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR® mRNA technology (sa-mRNA) and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus developed KOSTAIVE®, the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine in the world to be approved. Arcturus has an ongoing global collaboration with CSL Seqirus, U.S. BARDA for pandemic flu and a joint venture in Japan, ARCALIS, focused on the manufacture of mRNA vaccines and therapeutics. Arcturus’ pipeline includes RNA therapeutic candidates to potentially treat cystic fibrosis (CF) and ornithine transcarbamylase (OTC) deficiency along with its partnered mRNA vaccine programs for SARS-CoV-2 (COVID-19) and influenza. Arcturus’ versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA (siRNA), circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics. Arcturus' technologies are covered by its extensive patent portfolio (over 500 patents and patent applications in the U.S., Europe, Japan, China, and other countries). For more information, visit www.ArcturusRx.com. Please connect with us on X and LinkedIn.

Aivora

Aivora is a next-generation crypto exchange, combining AI-driven innovation with secure, efficient trading for global users. Our team brings expertise from leading exchanges to deliver futures, spot, and emerging assets like RWA, GameFi, and DeFi... ? Stay connected: Twitter: @AivoraEX Telegram: t.me/AivoraEX

Omics-OS

Why we exist Biology generates more data than it can use. A single multi-omics study produces terabytes across transcriptomics, proteomics, metabolomics, and clinical phenotypes. That data lands in incompatible formats, across disconnected tools, behind inconsistent access controls, with no shared governance. 80% of bioinformatics time goes to finding, curating, and reformatting data, not analyzing it. Data packages for pharma partnerships take 6 to 8 weeks of manual assembly. Every new study starts from zero because prior context is trapped on someone's laptop. The tools exist. They don't talk to each other. We fix that.

Backbone

Backbone is creating the software and devices platform for the future of gaming. The team hails from Apple, Google, Meta, and more. We're hiring across a variety of functions. Learn more: backbone.com/careers